ResMed Inc
(BSP:R1MD34)
R$
371.16
0 (0%)
Market Cap: 217.94 Bil
Enterprise Value: 220.49 Bil
PE Ratio: 33.02
PB Ratio: 7.04
GF Score: 85/100 Resmed Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 10, 2020 / 10:00PM GMT
Release Date Price:
R$295
Gretel Janu;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
All right. Hi, everyone. So my name is Gretel Janu. So I've got here, Mick Farrell, CEO of ResMed; and Dave Pendarvis, CAO of ResMed.
So Mick, David, thank you very much for your time today for joining our conference. Now it's great to have you here virtually.
Questions & Answers
Gretel Janu;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
So I think to start us off, Mick, do you want to start off to give us an update as to how the business has performed during COVID? A quick highlight of the latest results, given they were just a couple of weeks ago, and then we'll jump into some of the questions.
Michael J. Farrell
ResMed Inc. - CEO & Director
Yes. Sounds good, Gretel. I'll do just a very brief maybe 3-minute intro, and then allow the bulk of the time, Gretel, for you to facilitate Q&A from the team that's on.
So look, incredible 2020 here with
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot